The Carlat Psychiatry Podcast podcast

A New FDA Approval Brings New Psychiatric Risks

0:00
16:43
Reculer de 15 secondes
Avancer de 15 secondes

The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.

CME: Take the CME Post-Test for this Episode

Published On: 09/01/2025

Duration: 16 minutes, 42 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

D'autres épisodes de "The Carlat Psychiatry Podcast"